We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$227M
AUM Growth
-$15.9M
Cap. Flow
-$6.57M
Cap. Flow %
-2.89%
Top 10 Hldgs %
7.9%
Holding
407
New
8
Increased
60
Reduced
329
Closed
10

Top Buys

Rank Stock Value
1
XFLT
XAI Floating Rate & Alternative Income Trust
XFLT
+$689K
2
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
+$551K
3
FRA icon
BlackRock Floating Rate Income Strategies Fund
FRA
+$468K
4
ENIC icon
Enel Chile
ENIC
+$430K
5
EFT
Eaton Vance Floating-Rate Income Trust
EFT
+$429K

Top Sells

Rank Stock Value
1
GRA
W.R. Grace & Co.
GRA
+$1.73M
2
BGX
Blackstone Long-Short Credit Income Fund
BGX
+$731K
3
BGB
Blackstone Strategic Credit 2027 Term Fund
BGB
+$693K
4
NOA
North American Construction
NOA
+$554K
5
MCI
Barings Corporate Investors
MCI
+$524K

Sector Composition

Rank Sector Weight
1 Healthcare 25.28%
2 Real Estate 19.7%
3 Energy 13.28%
4 Utilities 12%
5 Materials 10.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRNX icon
226
Crinetics Pharmaceuticals
CRNX
$8.88B
$236K 0.1%
11,225
-585
-5% -$12.2K
KLRS
227
Kalaris Therapeutics
KLRS
$79.5M
$235K 0.1%
407
-21
-5% -$9.73K
ANAB icon
228
AnaptysBio
ANAB
$1.54B
$232K 0.1%
8,537
-450
-5% -$11.4K
APLS
229
DELISTED
Apellis Pharmaceuticals
APLS
$232K 0.1%
7,052
-641
-8% -$36K
NGM
230
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$230K 0.1%
10,924
-577
-5% -$12.7K
ALEC icon
231
Alector
ALEC
$169M
$229K 0.1%
10,039
-517
-5% -$14.5K
CDXS icon
232
Codexis
CDXS
$136M
$229K 0.1%
9,865
-520
-5% -$12.3K
TVRD
233
Tvardi Therapeutics
TVRD
$22.9M
$229K 0.1%
411
-22
-5% -$11K
CUE icon
234
Cue Biopharma
CUE
$127M
$228K 0.1%
521
-27
-5% -$9.42K
FIV
235
DELISTED
First Trust Senior Floating Rate 2022 Target Term Fund Common Shares of Beneficial Interest
FIV
$228K 0.1%
23,625
-2,605
-10% -$24.9K
EDIT icon
236
Editas Medicine
EDIT
$402M
$227K 0.1%
5,518
-288
-5% -$15.8K
IMTX icon
237
Immatics
IMTX
$1.19B
$227K 0.1%
17,438
-912
-5% -$11.6K
QTTB icon
238
Q32 Bio
QTTB
$467M
$226K 0.1%
1,599
-83
-5% -$10.6K
CCCC icon
239
C4 Therapeutics
CCCC
$393M
$225K 0.1%
5,043
-269
-5% -$11.5K
ORIC icon
240
Oric Pharmaceuticals
ORIC
$1.23B
$225K 0.1%
10,782
-567
-5% -$11.5K
GRTS
241
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$225K 0.1%
20,837
-1,093
-5% -$9.95K
MRTX
242
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$221K 0.1%
1,249
-69
-5% -$11.1K
NKTX icon
243
Nkarta
NKTX
$159M
$220K 0.1%
7,921
-416
-5% -$13.2K
VKTX icon
244
Viking Therapeutics
VKTX
$3.93B
$220K 0.1%
34,971
-1,820
-5% -$11.2K
IOVA icon
245
Iovance Biotherapeutics
IOVA
$2.1B
$219K 0.1%
8,901
-470
-5% -$11.1K
SRRK icon
246
Scholar Rock
SRRK
$5.92B
$219K 0.1%
6,624
-351
-5% -$12.3K
MYOV
247
DELISTED
Myovant Sciences Ltd.
MYOV
$219K 0.1%
9,755
-515
-5% -$11.3K
AGEN
248
Agenus
AGEN
$275M
$217K 0.1%
2,107
-110
-5% -$12.4K
NRIX icon
249
Nurix Therapeutics
NRIX
$2.51B
$216K 0.1%
7,193
-377
-5% -$11.6K
ALLO icon
250
Allogene Therapeutics
ALLO
$573M
$215K 0.09%
8,379
-438
-5% -$10.4K
8 9
10
11 12

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Virtus ETF Advisers held 407 positions worth $227M, down 6.5% from $243M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.4%. Virtus ETF Advisers opened 8 new positions and exited 10, leaving the 407-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Real Estate and Energy.

  • Virtus ETF Advisers's largest Q3 2021 buy was XAI Floating Rate & Alternative Income Trust: 15,447 shares worth $663K.
  • Virtus ETF Advisers added most to Enel Chile in Q3 2021, an estimated $430K increase.
  • Virtus ETF Advisers's biggest Q3 2021 reduction was North American Construction, cutting an estimated $554K.
  • Virtus ETF Advisers fully exited W.R. Grace & Co. in Q3 2021, selling an estimated $1.73M.
  • Virtus ETF Advisers's ten largest holdings make up 7.9% of its $227M portfolio in Q3 2021.
  • Virtus ETF Advisers opened 8 new positions and closed 10 in Q3 2021.
  • Virtus ETF Advisers's portfolio value fell 6.5% quarter-over-quarter to $227M.

Based on Virtus ETF Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.